达卫可®(莱博雷生片)
Search documents
2025年银发健康消费觉醒元年 京东健康正在托举“一种很新的养老方式”
Mei Ri Jing Ji Xin Wen· 2025-12-26 04:15
每经编辑|蒙锦涛 当年轻人仍在为满减券精打细算时,银发群体已悄然成为2025年中国健康经济一股不可忽视的力量。 临近年底,上海76岁的张奶奶又在京东健康"囤"足了够用半年的降压药和降糖药。与往年不同的是,今年在购药时,她第一次尝试和京东药师"对话",尝 试了免费的用药咨询。 过去面对家里越来越多的药盒,她总有些理不清,偶尔也会忘记服药,有时候想起来吃药发现药过期了,更不太懂不同药品之间的相互作用。今年,在医 生和药师的帮助下,她清晰了解了自己所服药品的详细注意事项和最佳服用时间,系统还为她和家人生成了个性化用药提醒。 这是今年以来在京东平台上每天都在发生的真实生活切片,也是银发消费持续升温的生动写照。 上海市消保委发布的《上海新银发群体消费习惯调查报告》指出,超六成新银发群体退休后对生活品质的要求有所上升。与传统认知中追求"低价实用"的 老一辈不同,当代银发族已经不满足于基础的"养老"生活需求,而更愿意追求"享老"生活质量的提升,从追求"性价比"到"智能化",消费风向正在转变。 "囤货"慢病用药常备药 银发族成"健康经济"新主力 "以前只知道京东买药便宜,所以会集中囤,心里其实对怎么吃好药、管好药是没底的。现 ...
京东健康(06618) - 内幕消息2025年第三季度之未经审计最新资料
2025-11-13 08:35
JD Health International Inc. 京東健康股份有限公司 (於開曼群島註冊成立的有限公司) (股份代號:6618(港幣櫃台)及86618(人民幣櫃台)) 內幕消息 2025 年第三季度之未經審計最新資料 本公告乃由京东健康股份有限公司(「本公司」或「京東健康」,連同其子公司及關聯併表 實體統稱「本集團」)根據香港聯合交易所有限公司(「聯交所」)證券上市規則(「上市規 則」)第13.09條及香港法例第571章證券及期貨條例第XIVA部項下的內幕消息條文(定義 見上市規則)而刊發。 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責,對其準確性或完整性亦不發表 任何聲明,並明確表示概不就因本公告全部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何 責任。 業務最新資料 2025年第三季度,京東健康與禮來、信達生物、衛材中國及拜耳中國等知名藥企簽署戰 略合作協定。衛材藥企旗下原研新藥達衛可® (萊博雷生片)、恒瑞旗下乾眼症新藥恆沁® (全氟己基辛烷滴眼液)、拜耳旗下達喜® 乳果糖等新藥也選擇在京東健康全網首發,繼 續鞏固京東健康「新特藥全網首發第一站」心智。除藥 ...
京东大药房上线睡眠中心 在线问诊+送药到家缓解用户失眠难题
Zheng Quan Ri Bao· 2025-09-23 14:12
Core Viewpoint - JD Health's launch of a sleep center and internet sleep clinic aims to provide comprehensive, professional, and personalized sleep health solutions to millions suffering from sleep issues, integrating internet healthcare with health management [2][3]. Group 1: Market Demand and Context - Sleep issues are increasingly recognized as a significant health challenge, with nearly 25% of the population in China sleeping less than 6 hours and about 40% experiencing nighttime awakenings [2]. - The International Classification of Diseases (ICD-11) identifies over 90 types of sleep disorders, indicating a broad and urgent demand for diagnosis and treatment [2]. Group 2: Government Initiatives - The National Health Commission and the National Disease Control Bureau have mandated that by 2025, each city must have at least one hospital offering sleep clinic services, with similar requirements for districts in direct-controlled municipalities [3]. - The establishment of JD Health's sleep center aligns with national policies aimed at enhancing sleep disorder services [3]. Group 3: Service Offerings - JD Health's sleep center will utilize a combination of professional assessments and collaboration with top-tier hospital psychiatrists to provide comprehensive evaluations of users' sleep and psychological stress [3]. - The center will also feature an AI psychological companion, "Chatting with Yu Universe," available 24/7 to help alleviate user stress and promote healthy sleep [3]. Group 4: Product Availability - Users will have the option to purchase various sleep-related products, including medications, breathing machines, and melatonin, facilitating a one-stop shopping experience [4]. - The recent launch of the innovative drug Dazhuike® (generic name: Levorotary) on JD Health's platform represents a new treatment option for insomnia patients by precisely regulating sleep-wake rhythms [4]. Group 5: Future Plans - JD Health plans to deepen collaborations with medical institutions and experts to continuously improve service models and enhance user experience in sleep health services [4].